Alyeska Investment Group, L.P. - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,574,000
+46.8%
392,600
-30.5%
0.02%
+35.7%
Q1 2021$1,072,000
+325.4%
564,500
+404.3%
0.01%
+250.0%
Q4 2020$252,000
+13.5%
111,929
+0.0%
0.00%
+33.3%
Q3 2020$222,000
-94.7%
111,916
-94.4%
0.00%
-95.2%
Q2 2020$4,199,000
+416.5%
2,008,804
+290.6%
0.06%
+293.8%
Q1 2020$813,000
+41.1%
514,2850.0%0.02%
+100.0%
Q4 2019$576,000
-4.3%
514,2850.0%0.01%
-11.1%
Q3 2019$602,000
-34.6%
514,2850.0%0.01%
-25.0%
Q2 2019$921,000
-4.3%
514,2850.0%0.01%
-7.7%
Q1 2019$962,000514,2850.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders